Release Date: October 30, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide an update on the nonaccrual loans and the expected timelines for their resolution? A: Daniel Devorsetz, COO and CIO, explained that some nonaccrual loans were resolved in Q3 through acquisitions or other transactions. A few others are still being worked on and may be resolved in Q4 or the first half of 2025, each with its own specific timeline and strategy.
Q: How did the resolutions of nonaccrual loans in Q3 compare to your expectations? A: Daniel Devorsetz noted that one loan, Nexii, was resolved by selling assets to a high-quality buyer, resulting in debt and equity in the new company. Gerald Michaud, President, added that Evelo's life science assets were consolidated into a holding company, with transactions underway to monetize these assets and pay down Horizon's loan.
Q: Can you discuss the current market environment and pipeline for new deals? A: Daniel Devorsetz stated that the market is improving, with a strong pipeline of quality opportunities. Although some deals have been awarded, they have not yet closed. The expectation is for Q4 to be a growth quarter, with the pipeline at its strongest in a while.
Q: How do you plan to manage the balance sheet and cover the dividend given the current cash levels and NII? A: Daniel Trolio, CFO, explained that they plan capital sources each quarter based on expected funding needs, using cash, debt facilities, and equity. The venture debt portfolio generates prepayments annually, which helps cover distributions over time.
Q: What factors dictate the pace of share sales through the ATM program? A: Daniel Trolio mentioned that the pace is determined by comparing capital sources to expected funding needs each quarter. The volume of trading in the ATM and debt facility capacity also influence the decision.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。